Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis.
Chen YL, Gutowska-Owsiak D, Hardman CS, Westmoreland M, MacKenzie T, Cifuentes L, Waithe D, Lloyd-Lavery A, Marquette A, Londei M, Ogg G.
Chen YL, et al. Among authors: lloyd lavery a.
Sci Transl Med. 2019 Oct 23;11(515):eaax2945. doi: 10.1126/scitranslmed.aax2945.
Sci Transl Med. 2019.
PMID: 31645451
Clinical Trial.